There is currently no specific treatment for metatarsus adductus (MTA), leading to a certain amount of confusion over when and how to treat MTA in infants. The lack of a specific solution for MTA has left orthopedic centers no choice but to adapt the casting technique indicated for club foot.
This casting technique comes with a number of disadvantages and complications. Due to problematic casting procedure in MTA there have been some understatement and compromising attitude about the treatment indications. There is no doubt that most of complications and surgical interventions can be avoided by adequate treatment in the first months of infant life.
Benefits of UNFO
Unlike serial casting, The UNFO brace was specifically designed to treat metatarsus adductus (MTA) patients. UNFO is far superior, safer and less stressful than serial casting for the treatment of MTA of any severity. Additionally, UNFO places the responsibility of treating mild to moderate patients in the physician’s hands rather than relying on the parents’ ability to correctly perform stretching exercises on their baby’s feet several times a day for weeks and months as a compromising “wait-and-see” treatment. As there is no need to “wait and see” whether stretching is an effective treatment for the infant, UNFO prevents the risk of failing to treat infants with MTA in time.
With UNFO, parents can be assured that their baby will be correctly treated from the start. The patient benefits from an innovative and state-of-the-art treatment while the physician gains credibility and the ability to effectively treat all forms of MTA. Moreover, insurance providers gain the benefit of a cost-effective treatment.
Why Choose UNFO